Brief Overview of MERS: Middle East Respiratory Syndrome
DOI:
https://doi.org/10.58344/jws.v3i11.1226Keywords:
coronavirus, dromedary camels, MERS, nucleocapsid protein, pandemic, respiratory illnessAbstract
Middle East Respiratory Syndrome (MERS) is a zoonotic disease caused by MERS-CoV, a beta coronavirus with a mortality rate of approximately 35%. The disease exhibits a wide range of clinical symptoms, from mild respiratory issues to severe conditions like multi-organ failure and pneumonia. Person-to-person transmission has led to significant hospital and community outbreaks, underscoring the urgent need for effective infection control measures. This study explores MERS-CoV's epidemiology, pathogenesis, and transmission dynamics, aiming to enhance understanding of its replication, spread, and control strategies due to limited pharmaceutical interventions. A comprehensive review of current literature was conducted, focusing on epidemiological data, genetic characteristics, and transmission patterns across affected regions, including the Middle East, Asia, Africa, and North America. Findings indicate that MERS-CoV originated from recombination events in the spike protein of African dromedaries and spread to the Arabian Peninsula via camels. The virus affects not only humans but also domestic animals like sheep, cattle, horses, and pigs, with global transmission facilitated by travelers, resulting in outbreaks in Asia and North America. Despite extensive research, no effective vaccines, antiviral drugs, or immune therapies control MERS-CoV. The findings emphasize the high pandemic potential of MERS-CoV due to its mortality rate and lack of effective treatments, highlighting the need for strict infection control and further research into viable therapeutic options.
References
Abd El Wahed, A., Patel, P., Heidenreich, D., Hufert, F. T., & Weidmann, M. (2013). Reverse transcription recombinase polymerase amplification assay for the detection of middle East respiratory syndrome coronavirus. PLoS Currents, 5.
Abdelfattah, M. M., El-Hammady, M. A., Mostafa, A., Kutkat, O., Abo Shama, N. M., Nafie, M. S., El-Ebeedy, D. A., & Abdel Azeiz, A. Z. (2023). Identification of potential antiviral compounds from Egyptian Red Sea soft corals against Middle East respiratory syndrome coronavirus. Natural Product Research. https://doi.org/10.1080/14786419.2023.2247535
Abdelrahman, Z., Li, M., & Wang, X. (2020). Comparative review of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza a respiratory viruses. Frontiers in Immunology, 11, 552909.
Abdullah Assiri, A. A., Al-Tawfiq, J. A., Al-Rabeeah, A. A., Al-Rabiah, F. A., Sami Al-Hajjar, S. A.-H., Ali Al-Barrak, A. A.-B., Hesham Flemban, H. F., Al-Nassir, W. N., Balkhy, H. H., & Al-Hakeem, R. F. (2013). Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study.
Abolfotouh, M. A., AlQarni, A. A., Al-Ghamdi, S. M., Salam, M., Al-Assiri, M. H., & Balkhy, H. H. (2017). An assessment of the level of concern among hospital-based health-care workers regarding MERS outbreaks in Saudi Arabia. BMC Infectious Diseases, 17, 1–10.
Ahmed, R., Robinson, R., & Mortimer, K. (2017). The epidemiology of noncommunicable respiratory disease in sub-Saharan Africa, the Middle East, and North Africa. Malawi Medical Journal, 29(2), 203–211.
Ajlan, A. M., Abourokbah, N. H., Alturkistani, S., Ahyad, R. A., Alharthy, A., Ashour, M., Wali, G., & Madani, T. A. (2022). Revisiting Middle East Respiratory Coronavirus (MERS-CoV) Outbreak Chest Radiographic Initial Findings, Temporal Progression, and Correlation to Outcomes: A Multicenter Study. Cureus, 14(5).
Aleebrahim-Dehkordi, E., Soveyzi, F., Deravi, N., Rabbani, Z., Saghazadeh, A., & Rezaei, N. (2021). Human coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in children. Journal of Pediatric Nursing, 56, 70–79.
Almutairi, K. M., Alodhayani, A. A., Moussa, M., Aboshaiqah, A. E., Tumala, R. B., & Vinluan, J. M. (2016). Ebola outbreak preparedness and preventive measures among healthcare providers in Saudi Arabia. The Journal of Infection in Developing Countries, 10(08), 829–836.
Alserehi, H., Wali, G., Alshukairi, A., & Alraddadi, B. (2016). Impact of Middle East Respiratory Syndrome coronavirus (MERS?CoV) on pregnancy and perinatal outcome. BMC Infectious Diseases, 16, 1–4.
Al-Tawfiq, J. A., & Memish, Z. A. (2016). Drivers of MERS-CoV transmission: what do we know? Expert Review of Respiratory Medicine, 10(3), 331–338.
Arabi, Y. M., Balkhy, H. H., Hayden, F. G., Bouchama, A., Luke, T., Baillie, J. K., Al-Omari, A., Hajeer, A. H., Senga, M., & Denison, M. R. (2017). Middle East respiratory syndrome. New England Journal of Medicine, 376(6), 584–594.
Azhar, E. I., El-Kafrawy, S. A., Farraj, S. A., Hassan, A. M., Al-Saeed, M. S., Hashem, A. M., & Madani, T. A. (2014). Evidence for camel-to-human transmission of MERS coronavirus. New England Journal of Medicine, 370(26), 2499–2505.
Azhar, E. I., Hui, D. S. C., Memish, Z. A., Drosten, C., & Zumla, A. (2019). The middle east respiratory syndrome (MERS). Infectious Disease Clinics, 33(4), 891–905.
Azhar, E. I., Velavan, T. P., Rungsung, I., Traore, T., Hui, D. S., McCloskey, B., El-Kafrawy, S. A., & Zumla, A. (2023). Middle East respiratory syndrome coronavirus—a 10-year (2012-2022) global analysis of human and camel infections, genomic sequences, lineages, and geographical origins. International Journal of Infectious Diseases, 131, 87–94. https://doi.org/10.1016/j.ijid.2023.03.046
Babarinsa, I. A., Okunoye, G. O., & Odukoya, O. (2021). Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-1) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in pregnancy – An overview. European Journal of Obstetrics and Gynecology and Reproductive Biology, 263, 171–175. https://doi.org/10.1016/j.ejogrb.2021.06.020
Baharoon, S., & Memish, Z. A. (2019). MERS-CoV as an emerging respiratory illness: a review of prevention methods. Travel Medicine and Infectious Disease, 32, 101520.
Bin, S. Y., Heo, J. Y., Song, M.-S., Lee, J., Kim, E.-H., Park, S.-J., Kwon, H., Kim, S. mi, Kim, Y., & Si, Y.-J. (2016). Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea. Clinical Infectious Diseases, 62(6), 755–760.
Biswas, S., Mita, M. A., Afrose, S., Hasan, M. R., Shimu, M. S. S., Zaman, S., & Saleh, M. A. (2024). An in silico approach to develop potential therapies against Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Heliyon, 10(4). https://doi.org/10.1016/j.heliyon.2024.e25837
Chan, J. F.-W., Yao, Y., Yeung, M.-L., Deng, W., Bao, L., Jia, L., Li, F., Xiao, C., Gao, H., & Yu, P. (2015). Treatment with lopinavir/ritonavir or interferon-?1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset. The Journal of Infectious Diseases, 212(12), 1904–1913.
Cheng, V. C. C., Chan, J. F. W., To, K. K. W., & Yuen, K. Y. (2013). Clinical management and infection control of SARS: lessons learned. Antiviral Research, 100(2), 407–419.
Chong, Y. P., Song, J. Y., Seo, Y. Bin, Choi, J.-P., Shin, H.-S., & Team, R. R. (2015). Antiviral treatment guidelines for Middle East respiratory syndrome. Infection & Chemotherapy, 47(3), 212.
Corman, V. M., Eckerle, I., Bleicker, T., Zaki, A., Landt, O., Eschbach-Bludau, M., van Boheemen, S., Gopal, R., Ballhause, M., & Bestebroer, T. M. (2012). Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Eurosurveillance, 17(39).
De Wit, E., Van Doremalen, N., Falzarano, D., & Munster, V. J. (2016). SARS and MERS: recent insights into emerging coronaviruses. Nature Reviews Microbiology, 14(8), 523–534.
Dyall, J., Gross, R., Kindrachuk, J., Johnson, R. F., Olinger Jr, G. G., Hensley, L. E., Frieman, M. B., & Jahrling, P. B. (2017). Middle East respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies. Drugs, 77(18), 1935–1966.
Elhazmi, A., Al-Tawfiq, J. A., Sallam, H., Al-Omari, A., Alhumaid, S., Mady, A., & Al Mutair, A. (2021). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) coinfection: A unique case series. Travel Medicine and Infectious Disease, 41. https://doi.org/10.1016/j.tmaid.2021.102026
Fehr, A. R., Channappanavar, R., & Perlman, S. (2017). Middle East respiratory syndrome: emergence of a pathogenic human coronavirus. Annual Review of Medicine, 68(1), 387–399.
Ford, N., Vitoria, M., Rangaraj, A., Norris, S. L., Calmy, A., & Doherty, M. (2020). Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID?19: initial assessment. Journal of the International AIDS Society, 23(4), e25489.
Guarner, J. (2020). Three emerging coronaviruses in two decades: the story of SARS, MERS, and now COVID-19. In American journal of clinical pathology (Vol. 153, Issue 4, pp. 420–421). Oxford University Press US.
Haagmans, B. L., van den Brand, J. M. A., Provacia, L. B., Raj, V. S., Stittelaar, K. J., Getu, S., de Waal, L., Bestebroer, T. M., van Amerongen, G., & Verjans, G. M. G. M. (2015). Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits. Journal of Virology, 89(11), 6131–6135.
Hemida, M. G., Elmoslemany, A., Al?Hizab, F., Alnaeem, A., Almathen, F., Faye, B., Chu, D. K. W., Perera, R. A. P. M., & Peiris, M. (2017). Dromedary camels and the transmission of Middle East respiratory syndrome coronavirus (MERS?CoV). Transboundary and Emerging Diseases, 64(2), 344–353.
Hui, D. S., Azhar, E. I., Kim, Y.-J., Memish, Z. A., Oh, M., & Zumla, A. (2018). Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. The Lancet Infectious Diseases, 18(8), e217–e227.
Jolly, G. (2016). Middle East respiratory syndrome coronavirus (MERS-CoV). TEXILA INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 4(4), 351–376.
Kandeel, M. (2022). Meta-analysis of seroprevalence and zoonotic infections of Middle East respiratory syndrome coronavirus (MERS-CoV): A one-health perspective. One Health, 15. https://doi.org/10.1016/j.onehlt.2022.100436
Kelly-Cirino, C., Mazzola, L. T., Chua, A., Oxenford, C. J., & Van Kerkhove, M. D. (2019). An updated roadmap for MERS-CoV research and product development: focus on diagnostics. BMJ Global Health, 4(Suppl 2), e001105.
Ko, M., Chang, S. Y., Byun, S. Y., Ianevski, A., Choi, I., Pham Hung d’Alexandry d’Orengiani, A.-L., Ravlo, E., Wang, W., Bjørås, M., & Kainov, D. E. (2021). Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19. Viruses, 13(4), 651.
Lee, J. H., Kim, J. W., Lee, H. E., Song, J. Y., Cho, A. H., Hwang, J. H., Heo, K., & Lee, S. (2024). A dual-targeting approach using a human bispecific antibody against the receptor-binding domain of the Middle East Respiratory Syndrome Coronavirus. Virus Research, 345. https://doi.org/10.1016/j.virusres.2024.199383
Lee, K. H., Yoon, S., Jeong, G. H., Kim, J. Y., Han, Y. J., Hong, S. H., Ryu, S., Kim, J. S., Lee, J. Y., & Yang, J. W. (2020). Efficacy of corticosteroids in patients with SARS, MERS and COVID-19: a systematic review and meta-analysis. Journal of Clinical Medicine, 9(8), 2392.
Li, F., & Du, L. (2019). MERS coronavirus: an emerging zoonotic virus. In Viruses (Vol. 11, Issue 7, p. 663). MDPI.
Licina, A., Silvers, A., & Stuart, R. L. (2020). Use of powered air-purifying respirator (PAPR) by healthcare workers for preventing highly infectious viral diseases—a systematic review of evidence. Systematic Reviews, 9, 1–13.
Mackay, I. M., & Arden, K. E. (2015). MERS coronavirus: diagnostics, epidemiology and transmission. Virology Journal, 12, 1–21.
Mahmood, T., Al-Duais, F. S., & Sun, M. (2022). Dynamics of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) involving fractional derivative with Mittag-Leffler kernel. Physica A: Statistical Mechanics and Its Applications, 606. https://doi.org/10.1016/j.physa.2022.128144
Majumder, M. S., Brownstein, J. S., Finkelstein, S. N., Larson, R. C., & Bourouiba, L. (2017). Nosocomial amplification of MERS-coronavirus in South Korea, 2015. Transactions of The Royal Society of Tropical Medicine and Hygiene, 111(6), 261–269.
Memish, Z. A., Perlman, S., Van Kerkhove, M. D., & Zumla, A. (2020). Middle East respiratory syndrome. The Lancet, 395(10229), 1063–1077.
Momattin, H., Al-Ali, A. Y., & Al-Tawfiq, J. A. (2019). A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Travel Medicine and Infectious Disease, 30, 9–18.
Mostafa, A., Kandeil, A., Shehata, M., El Shesheny, R., Samy, A. M., Kayali, G., & Ali, M. A. (2020). Middle east respiratory syndrome coronavirus (mers-cov): State of the science. Microorganisms, 8(7), 991.
Muhammad, G., & Akram, M. (2024). Fuzzy fractional epidemiological model for Middle East respiratory syndrome coronavirus on complex heterogeneous network using Caputo derivative. Information Sciences, 659. https://doi.org/10.1016/j.ins.2023.120046
Nam, H.-S., Park, J. W., Ki, M., Yeon, M.-Y., Kim, J., & Kim, S. W. (2017). High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea. International Journal of Infectious Diseases, 58, 37–42.
Nassar, M., Bakhrebah, M. A., Meo, S. A., Alsuabeyl, M. S., & Zaher, W. A. (2018). Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics. Eur Rev Med Pharmacol Sci, 22(15), 4956–4961.
Oboho, I. K., Tomczyk, S. M., Al-Asmari, A. M., Banjar, A. A., Al-Mugti, H., Aloraini, M. S., Alkhaldi, K. Z., Almohammadi, E. L., Alraddadi, B. M., & Gerber, S. I. (2015). 2014 MERS-CoV outbreak in Jeddah—a link to health care facilities. New England Journal of Medicine, 372(9), 846–854.
Organization, W. H. (2018). Laboratory testing for middle East respiratory syndrome coronavirus: interim guidance (revised), January 2018. World Health Organization.
Organization, W. H. (2019). Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected: interim guidance. World Health Organization.
Pan, Y., Guo, F., Bahoussi, A. N., Shi, R., Li, Y., & Xing, L. (2021). Genetic drift of MERS?CoV in Saudi Arabia during 2012–2019. Zoonoses and Public Health, 68(5), 527–532.
Park, S. E. (2020). Epidemiology, virology, and clinical features of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19). Clinical and Experimental Pediatrics, 63(4), 119.
Pormohammad, A., Ghorbani, S., Khatami, A., Farzi, R., Baradaran, B., Turner, D. L., Turner, R. J., Bahr, N. C., & Idrovo, J. (2020). Comparison of confirmed COVID?19 with SARS and MERS cases?Clinical characteristics, laboratory findings, radiographic signs and outcomes: a systematic review and meta?analysis. Reviews in Medical Virology, 30(4), e2112.
Rabaan, A. A., Al-Ahmed, S. H., Haque, S., Sah, R., Tiwari, R., Malik, Y. S., Dhama, K., Yatoo, M. I., Bonilla-Aldana, D. K., & Rodriguez-Morales, A. J. (2020). SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview. Infez Med, 28(2), 174–184.
Sarathy, D. M., Thandapani, K., Arunagirinathan, A., & Amirthalingam, U. (2022). Rare Clinico-radiological Syndrome Mimicking Transient Ischemic Attack-A Case Report. Journal of Nepal Paediatric Society, 42(2), 86–88.
Shchelkanov, M. Y., Popova, A. Y., Dedkov, V. G., Akimkin, V. G., & Maleyev, V. V. (2020). History of investigation and current classification of coronaviruses (Nidovirales: Coronaviridae). Russian Journal of Infection and Immunity, 10(2), 221–246.
Shirato, K., Semba, S., El-Kafrawy, S. A., Hassan, A. M., Tolah, A. M., Takayama, I., Kageyama, T., Notomi, T., Kamitani, W., & Matsuyama, S. (2018). Development of fluorescent reverse transcription loop-mediated isothermal amplification (RT-LAMP) using quenching probes for the detection of the Middle East respiratory syndrome coronavirus. Journal of Virological Methods, 258, 41–48.
Song, Z., Xu, Y., Bao, L., Zhang, L., Yu, P., Qu, Y., Zhu, H., Zhao, W., Han, Y., & Qin, C. (2019). From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses, 11(1), 59.
Tolentino, J. E., Lytras, S., Ito, J., & Sato, K. (2024). Recombination analysis on the receptor switching event of MERS-CoV and its close relatives: implications for the emergence of MERS-CoV. Virology Journal, 21(1), 84.
Vigant, F., Santos, N. C., & Lee, B. (2015). Broad-spectrum antivirals against viral fusion. Nature Reviews Microbiology, 13(7), 426–437.
Yan, Y., Chang, L., & Wang, L. (2020). Laboratory testing of SARS?CoV, MERS?CoV, and SARS?CoV?2 (2019?nCoV): Current status, challenges, and countermeasures. Reviews in Medical Virology, 30(3), e2106.
Yang, Y. L., Kim, J., Jeong, Y., & Jang, Y. S. (2022). Intranasal immunization with a Middle East respiratory syndrome-coronavirus antigen conjugated to the M-cell targeting ligand Co4B enhances antigen-specific mucosal and systemic immunity and protects against infection. Vaccine, 40(5), 714–725. https://doi.org/10.1016/j.vaccine.2021.12.057
Zhou, J., Chu, H., Chan, J. F.-W., & Yuen, K.-Y. (2015). Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesis. Virology Journal, 12, 1–7.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ayesha Nadeem, Hafiza Arshi Saeed, Ambreen Talib, Rabbya Rayan Shah, Rameen Atique, Abdul Samad
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
